AbbVie Inc. (ABBV)
AbbVie Max Pain By Strike
ABBV trades at $205.52, 8.2% above the near-term max pain of $190 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($170-$200), indicating stable market expectations. Key magnetic zone at 190 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
AbbVie Max Pain By Expiry
Max pain for ABBV shows stable levels around 187.50, reflecting balanced market expectations. The 16% spread signals divergent expectations across timeframes. Most levels below 205.52 may cap rallies. Strong magnetic level at 190 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 190 | -15.52 (-7.55%) |
| Aug 22, 2025 | 195 | -10.52 (-5.12%) |
| Aug 29, 2025 | 195 | -10.52 (-5.12%) |
| Sep 5, 2025 | 190 | -15.52 (-7.55%) |
| Sep 12, 2025 | 195 | -10.52 (-5.12%) |
| Sep 19, 2025 | 190 | -15.52 (-7.55%) |
| Sep 26, 2025 | 200 | -5.52 (-2.69%) |
| Oct 17, 2025 | 190 | -15.52 (-7.55%) |
| Nov 21, 2025 | 185 | -20.52 (-9.98%) |
| Dec 19, 2025 | 185 | -20.52 (-9.98%) |
| Jan 16, 2026 | 180 | -25.52 (-12.42%) |
| Feb 20, 2026 | 180 | -25.52 (-12.42%) |
| Mar 20, 2026 | 190 | -15.52 (-7.55%) |
| Jun 18, 2026 | 185 | -20.52 (-9.98%) |
| Sep 18, 2026 | 180 | -25.52 (-12.42%) |
| Jan 15, 2027 | 170 | -35.52 (-17.28%) |